Bausch Health Companies (TSE:BHC) Trading Up 0.3% – Should You Buy?

Shares of Bausch Health Companies Inc. (TSE:BHC) shot up 0.3% during mid-day trading on Monday . The company traded as high as C$7.56 and last traded at C$7.50. 128,862 shares changed hands during trading, a decline of 74% from the average session volume of 503,122 shares. The stock had previously closed at C$7.48.

Analysts Set New Price Targets

A number of brokerages have issued reports on BHC. Barclays upgraded Bausch Health Companies to a “hold” rating in a research report on Monday, December 8th. Raymond James Financial upgraded Bausch Health Companies to a “hold” rating in a research report on Monday, December 15th. Two research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company has a consensus rating of “Hold”.

Bausch Health Companies Stock Up 0.3%

The business has a fifty day simple moving average of C$7.65 and a 200 day simple moving average of C$8.72. The firm has a market cap of C$2.78 billion, a price-to-earnings ratio of 17.86, a PEG ratio of 0.21 and a beta of 0.59. The company has a debt-to-equity ratio of -3,835.02, a current ratio of 1.47 and a quick ratio of 0.58.

Bausch Health Companies (TSE:BHC) last announced its earnings results on Wednesday, February 18th. The company reported C($0.41) EPS for the quarter. Bausch Health Companies had a net margin of 1.82% and a negative return on equity of 20.27%. The firm had revenue of C$6.62 billion for the quarter. As a group, equities analysts forecast that Bausch Health Companies Inc. will post 5.5472637 EPS for the current fiscal year.

Bausch Health Companies Company Profile

Bausch Health Companies Inc is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries.